Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02573818 · ClinicalTrials.gov registry record
Sedasys Post Approval Study Users Response to System Alarms
A clinical trial, sponsored by Ethicon Endo-Surgery.
- Terminated
- Registry status
- 51
- Enrollment target
NCT02573818: Clinical Trial study, sponsored by Ethicon Endo-Surgery.
NCT02573818 is a clinical trial that was terminated before completion, run by Ethicon Endo-Surgery. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02573818 was terminated before completion, sponsored by Ethicon Endo-Surgery.
- TERMINATED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the users' responses to the SEDASYS® System alarms during esophagogastroduodenoscopy (EGD) or colonoscopy.
Interventions
- DEVICE SEDASYS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2016-06-15 |
Why NCT02573818 stopped before completion
NCT02573818 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SEDASYS System is the first listed.
NCT02573818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02573818 about?
NCT02573818 is a clinical study titled "Sedasys Post Approval Study Users Response to System Alarms". The purpose of this study is to evaluate the users' responses to the SEDASYS® System alarms during esophagogastroduodenoscopy (EGD) or colonoscopy.
What is the current status of trial NCT02573818?
This trial is currently terminated. The enrollment target is 51 participants. The study started on 2015-09-01. Estimated completion is 2016-06-15.
What interventions are being tested in trial NCT02573818?
The interventions under investigation include: SEDASYS System (DEVICE).
Who is sponsoring clinical trial NCT02573818?
This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI